Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Nadia Yousaf"'
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Autor:
Mary Y. Wu, Scott T.C. Shepherd, Annika Fendler, Edward J. Carr, Lewis Au, Ruth Harvey, Giulia Dowgier, Agnieszka Hobbs, Lou S. Herman, Martina Ragno, Lorin Adams, Andreas M. Schmitt, Zayd Tippu, Benjamin Shum, Sheima Farag, Aljosja Rogiers, Nicola O’Reilly, Philip Bawumia, Callie Smith, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Justine Korteweg, Tara Foley, Taja Barber, Stephanie Hepworth, Andrea Emslie-Henry, Niamh Caulfield-Lynch, Fiona Byrne, Daqi Deng, Bryan Williams, Michael Brown, Simon Caidan, Mike Gavrielides, James I. MacRae, Gavin Kelly, Kema Peat, Denise Kelly, Aida Murra, Kayleigh Kelly, Molly O’Flaherty, Sanjay Popat, Nadia Yousaf, Shaman Jhanji, Kate Tatham, David Cunningham, Nicholas Van As, Kate Young, Andrew J.S. Furness, Lisa Pickering, Rupert Beale, Charles Swanton, Sonia Gandhi, Steve Gamblin, David L.V. Bauer, George Kassiotis, Michael Howell, Susanna Walker, Emma Nicholson, James Larkin, Emma C. Wall, Samra Turajlic
Publikováno v:
Cancer Cell. 41:821-823
Autor:
Charlotte Milner-Watts, Hazel O’Sullivan, James Stewart, Praveena Idaikkadar, Nadza Tokaca, Michael Davidson, Nadia Yousaf, Jaishree Bhosle, Sanjay Popat, Mary O’Brien, Anna Minchom
Publikováno v:
Lung Cancer. 178:S31-S32
Autor:
Nadia Yousaf, Sheima Farag
Publikováno v:
Medicine. 49:548-553
The endocrine paraneoplastic manifestations of cancer are well described and result from ectopic hormone production by non-endocrine organs or direct hormone secretion from endocrine malignancies. However, an emergent and more common issue is that of
Publikováno v:
European Journal of Cancer. 166:38-40
Autor:
Jaishree Bhosle, Michael Davidson, Mary O'Brien, Anna Minchom, Mariam Obeid, Abdul Muhith, Sanjay Popat, Kroopa Joshi, Nadia Yousaf, C. Milner-Watts
Publikováno v:
Lung Cancer (Amsterdam, Netherlands)
Durvalumab is the first approved adjuvant immunotherapy agent for patients with stage III NSCLC treated with concurrent chemoradiotherapy and is associated with improved overall survival. In order to minimise the number of hospital visits for patient
Autor:
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D. Rosen, John Baksi, Rajdeep Khattar, Yulia Kirichenko, Kate Young, Nadia Yousaf, Alicia Okines, Robert Huddart, Kevin Harrington, Andrew Furness, Samra Turajlic, Lisa Pickering, Sanjay Popat, James Larkin, Alexander R. Lyon
Background: The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to describe the spectrum of cardiovascular adverse events (cvAEs) by presenting our real-world experie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8292b5c43875c401c3e9766ef7cd939d
https://doi.org/10.21203/rs.3.rs-1910265/v1
https://doi.org/10.21203/rs.3.rs-1910265/v1
Autor:
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D. Rosen, John Baksi, Rajdeep Khattar, Yulia Kirichenko, Kate Young, Nadia Yousaf, Alicia Okines, Robert Huddart, Kevin Harrington, Andrew J.S. Furness, Samra Turajlic, Lisa Pickering, Sanjay Popat, James Larkin, Alexander R. Lyon
Publikováno v:
Cardio-oncology (London, England). 8(1)
Background The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to describe the spectrum of cardiovascular adverse events (cvAEs) by presenting our real-world experien
Autor:
Alexandros, Georgiou, Nadia, Yousaf
Publikováno v:
Br J Cardiol
Publikováno v:
European journal of cancer (Oxford, England : 1990). 174
Autor:
Wanyuan Cui, Charlotte Milner-Watts, Hazel O'Sullivan, Hannah Lyons, Anna Minchom, Jaishree Bhosle, Michael Davidson, Nadia Yousaf, Sophie Scott, Iris Faull, Marina Kushnir, Rebecca Nagy, Mary O'Brien, Sanjay Popat
Publikováno v:
European journal of cancer (Oxford, England : 1990). 171
Genomic sequencing is necessary for first-line advanced non-small cell lung cancer (aNSCLC) treatment decision-making. Tissue next generation sequencing (NGS) is standard but tissue quantity, quality, and time-to-results remains problematic. Here, we